← Eichor
Study identifier: NCT07530718 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Body Composition Outcomes in MS Patients

Condition: Obesity  ·  Sponsor: Pennington Biomedical Research Center

PhaseN/A
Planned participants20
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Objectives The objective of this project is to generate pilot data substantiating our hypothesis that advanced body composition measurement tools will provide more accurate and clinically relevant data on the outcomes of metabolic surgery (MS) in patients with severe obesity compared to traditional methods. To achieve this objective, the investigators propose the following aims: Aim 1: Evaluate the effectiveness of different body composition measurement tools in assessing outcomes in patients with severe obesity undergoing MS. Aim 2: Assess the changes in body composition and muscle strength following MS. Aim 3: Compare body compositions changes between SG and RYGB patients.

This description comes directly from the study's public registry record.

Talk to the study team

Zubaidah Nor Hanipah, MD  ·  225-763-2831  ·  zubaidah.norhanipah@pbrc.edu

Always discuss trial participation with your own doctor first.

Locations (2)

Pennington Biomedical Resarch CenterBaton Rouge, Louisiana, United StatesNot Yet Recruiting
Pennington Biomedical Research CenterBaton Rouge, Louisiana, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07530718